Product Image
More sustainable than new
$228.85$549.70Save 58%

Product Details

Manufacturer
SKU
HPA035015ICC
Shipped From
Sweden

About this product

Anti-STAG1 Antibody

by Atlas Antibodies · SKU HPA035015

Overview

Anti-STAG1 is a primary antibody targeting human stromal antigen 1 (STAG1), a core component of the cohesin complex that plays a central role in sister chromatid cohesion, chromosome segregation, and maintenance of genome stability. The antibody is generated against a defined sequence from the human STAG1 protein.

This antibody is supplied under multiple SKUs, each validated by the manufacturer for a specific application.

Highlights

  • Targets human STAG1, a cohesin complex component
  • Associated with chromosome cohesion and genome stability
  • Sequence-defined immunogen
  • Application-specific validation by SKU

At-a-glance

Target protein
Stromal antigen 1 (STAG1)
Gene name
STAG1
Species reactivity
Human
Validated applications
Immunocytochemistry (ICC); Immunohistochemistry (IHC) — application dependent on SKU
Immunogen
Peptide corresponding to a region of the human STAG1 protein
Buffer composition
40% glycerol and PBS (pH 7.2), with 0.02% sodium azide
Condition
New / Unused — surplus stock

Applications

This antibody is intended for the detection and localisation of STAG1 in human-derived samples. Manufacturer validation supports use in immunocytochemistry and immunohistochemistry, depending on the specific SKU.

Sustainability

By rehoming surplus lab products, this listing supports waste reduction and resource efficiency.

Related Products

What Our Clients Say

Supporting innovation at leading research companies

RNAnalytics

RNAnalytics

Leading The Way In Gene Therapy Analytics

As a startup focused on developing analytical toolkits for LNP characterization, RNAnalytics operates under tight budget constraints while striving to maintain a fully stocked lab with high-quality materials. Sustainability is also a core pillar of our operations, pushing us to make environmentally conscious decisions wherever possible....